1. 486PProspective biomarker study in advanced RAS wild-type colorectal cancer: POSIBA trial. (23rd October 2018) Authors: García Albéniz, X; Alonso, V; Escudero, P; Méndez, M; Gallego Plazas, J; Rodriguez, J R; Salud Salvia, A; Fernández-Plana, J; Manzano Alemany, H; Zanui, M; Falcó, E; Feliu Batlle, J; Gil-Raga, M; Fernández-Martos, C; Bohn Sarmiento, U; Alonso López, M C; Calderero Aragón, V; Rojo, F; Cuatrecasas,... Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial. (14th November 2017) Authors: Abad, A; Martínez-Balibrea, E; Viéitez, J M; Alonso-Orduña, V; García Alfonso, P; Manzano, J L; Massutí, B; Benavides, M; Carrato, A; Zanui, M; Gallego, J; Grávalos, C; Conde, V; Provencio, M; Valladares-Ayerbes, M; Salazar, R; Sastre, J; Montagut, C; Rivera, F; Aranda, E Journal: Annals of oncology Issue: Volume 29:Number 2(2018) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗